1.Albendazole Therapy for Multiple Neurocysticercosis.
Journal of Korean Neurosurgical Society 1990;19(10-12):1422-1425
Albendazole is a new drug for the treatment of cerebral cysticercosis. We have recently experience a case that had shown poor therapeutic response to praziquantel. The patient have multiple parenchymal cysts. She was treated with 15mg/kg/day of albendazole for 1 month to confirm healing of the intracranial lesion by the follow up brain CT scan and CSF-ELISA associated with marked clinical improvement.
Albendazole*
;
Brain
;
Cysticercosis
;
Drug Therapy
;
Follow-Up Studies
;
Humans
;
Neurocysticercosis*
;
Praziquantel
;
Tomography, X-Ray Computed
2.Congenital Lobar Emphysema.
Cheal Gee KIM ; Do Hee CHOI ; Jin Bok HWANG ; Chang Ho HAN ; Hye Li CHANG ; Young Dae KWON
Journal of the Korean Pediatric Society 1994;37(3):429-433
We had experienced a case of congenital lobar emphysema in a 3 months old male infant. Chief symptoms included tachypenea, respiratory difficulty, cyanosis, Chest X-ray or chest CT scan revealed extensive emphysematous changes of the right upper and middle lobes, compression of the right lower lobe and shifted of mediastinum to the left side. This condition was appeared in the absence of infection and foreign body in the bronchus and its failure to respond to conservative treatment. This patient was treated by the right upper and right middle lobes pneumonectomy. A brief review of literature was made.
Bronchi
;
Cyanosis
;
Emphysema*
;
Foreign Bodies
;
Humans
;
Infant
;
Male
;
Mediastinum
;
Pneumonectomy
;
Thorax
;
Tomography, X-Ray Computed
3.The Effects of Glucose , Insulin and Angiotensin II on Plasminogen Activator Inhibitor-1 Expression and Growth of Aortic Vascular Smooth Muscle Cell in Rats.
Sae Young CHOI ; In Gyu LEE ; Sung Sae HAN ; Jae Hyun KIM ; Chang Kwon PARK ; Kwang Sook LEE ; Young Sun YOO ; Gee Sik KIM ; Yoon Neon KIM ; Kwon Bae KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1999;32(4):333-340
BACKGROUND: Plasminogen activator inhibitor-1(PAI-1) is known as the primary physiological inhibitor of tissue-type plasminogen activator(t-PA) in the plasma, and is present within the atherosclerotic vessels. Increased plasma levels of PAI-1 are one of the major disturbances of the hemostatic system in patients with diabetes and/or hypertension, and may have multiple interrelations with the important risk factors in the development of atherosclerosis. This study was performed to determine whether altered gene expression of PAI-1 occurs within the arterial wall, and thereby potentially contributing to the increase of cardiovascular risks associated with diabetes and/or hypertension. MATERIAL AND METHOD: The aortic vascular smooth muscle cells of the rat were exposed to 22 mM glucose, angiotensin II, and insulin increased PAI-1 mRNA expression with the use of Northern blotting were examined. Also examined were the effects of 22 mM glucose, angiotensin II and insulin on the growth of the rat's aortic smooth muscle cells by using MTT assay. RESULT: Twenty-two mM glucose treatment increased the PAI-1 mRNA expression in a time- and dose-dependent manner. Aniotensin II treatment synergistically increased the glucose-induced PAI-1 mRNA expression. In contrast, addition of insulin attenuated the increase of 22 mM glucose and angiotensin II induced PAI-1 mRNA expression. Furthermore, treatment of 22 mM glucose, angiotensin II and insulin resulted in a significant increase in cell numbers. This study demonstrated that 22 mM glucose and angiotensin II have a synergistic effect in stimulating the PAI-1 mRNA expression and in the cell growth of the rat's aortic smooth muscle cells. CONCLUSION: Elevation of glucose and angiotensin II may be important risk factors in impairing fibrinolysis and developing atherosclerosis in diabetic patients.
Angiotensin II*
;
Angiotensins*
;
Animals
;
Atherosclerosis
;
Blotting, Northern
;
Cell Count
;
Fibrinolysis
;
Gene Expression
;
Glucose*
;
Humans
;
Hypertension
;
Insulin*
;
Muscle, Smooth, Vascular*
;
Myocytes, Smooth Muscle
;
Plasma
;
Plasminogen Activator Inhibitor 1
;
Plasminogen Activators*
;
Plasminogen*
;
Rats*
;
Risk Factors
;
RNA, Messenger
4.The Characteristics of Bronchioloalveolar Carcinoma Presenting with Solitary Pulmonary Nodule.
Ho Cheol KIM ; Eun Mee CHEON ; Gee Young SUH ; Man Pyo CHUNG ; Ho Joong KIM ; O Jung KWON ; Chong H RHEE ; Yong Chol HAN ; Kyoung Soo LEE ; Jung Ho HAN
Tuberculosis and Respiratory Diseases 1997;44(2):280-289
BACKGROUND: Bronchioloalveolar carcinoma (BAC) has been reported to diveres spectrum of chinical presentations and radiologic patterns. The three representative radiologic patterns are followings; 1) a solitary nodule or mass, 2) a localized consolidation, and 3) multicentric or diffuse disease. While, the localized consolidation and solitary nodular patterns has favorable prognosis, the multicentric of diffuse pattern has worse prognosis regardless of treatment BAC presenting as a solitary pulmonary nodule is often misdiagnosed as other benign disease such as tuberculoma. Therefore it is very important to make proper diagnosis of BAC with solitary nodular pattern, since this pattern of BAC is usually curable with a surgical resection. METHODS: We reviewed the clinical and radiologic features of patients with pathologically-proven BAC with solitary nodular pattern from January 1995 to September 1996 at Samsung Medical Center. RESULTS: Total 11 patients were identified. 6 were men and 5 were women. Age ranged from 37 to 69. Median age was 60. Most patients with BAC with solitary nodular pattern were asymptomatic and were detected by incidental radiologic abnormality. The chest radiograph showed poorly defined opacity or nodule and computed tomography showed consolidation, ground glass appearance, internal bubble-like lucencies, air bronchogram, open bronchus sign, spiculated margin or pleural tag in most patients. The initial diagnosis on chest X-ray were pulmonary tuberculosis in 4 patients, benign nodule in 2 patients and malignant nodule in 5 patients. The FDG-positron emission tomogram was performed in eight patients. The FDG-PET revealed suggestive findings of malignancy in only 3 patients. The pathologic diagnosis was obtained by transbronchial lung biopsy in 1 patient, by CT guided percutaneous needle aspiration in 2 patients, and by lung biopsy via video-assited thoracocopy in 8 patients. Lobectomy was performed in all patients and postoperative pathologic staging were T1N0M0 in 8 patients and T2N0M0 in 3 patients. CONCLUSION: Patients of BAC presenting with solitary nodular pattern were most often asymptomatic and incidentally detected by radiologic abnormality. The chest X-ray showed poorly defined nodule or opacity and these findings were often regarded as benign lesion. If poorly nodule or opacity does not disappear on follow up chest X-ray, computed tomography should be performed. If consolidation, ground glass appearance, open bronchus sign, air bronchogram, internal bubble like lucency, pleural tag or spiculated margin are found on computed tomography, further diagnostic procedures, including open thoracotomy, should be performed to exclude the possiblity of BAC with solitary nodular pattern.
Adenocarcinoma, Bronchiolo-Alveolar*
;
Biopsy
;
Bronchi
;
Diagnosis
;
Female
;
Follow-Up Studies
;
Glass
;
Humans
;
Lung
;
Male
;
Needles
;
Prognosis
;
Radiography, Thoracic
;
Solitary Pulmonary Nodule*
;
Thoracotomy
;
Thorax
;
Tuberculoma
;
Tuberculosis, Pulmonary
5.Clinical differential diagnosis of usual interstitial pneumonia from nonspecific interstitial pneumonia.
Chang Hyeok AN ; Young Min KOH ; Man Pyo CHUNG ; Gee Young SUH ; Soo Jung KANG ; Kyeong Woo KANG ; Jong Woon AHN ; Si Young LIM ; Ho Joong KIM ; Joung Ho HAN ; Kyung Soo LEE ; O Jung KWON ; Chong H RHEE
Tuberculosis and Respiratory Diseases 2000;48(6):932-943
BACKGROUND: Nonspecific interstitial pneumonitis (NSIP) is most likely to be confused with usual interstitial pneumonitis (UIP). Unlike patients with UIP, the majority of patients with NSIP have a good prognosis, with most patients improving after treatment with corticosteroids. Therefore it is clinically important to differentiate NSIP from UIP. UP to now, the only means of differentiating these two diseases was by means of surgical lung biopsy. American Thoracic Society (ATS) proposed a clinical diagnostic criterial for UIP to provide assistance to clinicians in its diagnosis without surgical lung biopsy. This study is aimed to investigate whether there were clinical and radiological differences between NSIP and UIP, and the usefulness of ATS clinical diagnostic criteria for UIP in Korea. METHODS: we studied 60 patients with UIP and NSIP confirmed by surgical lung biopsy. Clinical manifestations, pulmonary function test, arterial blood gas analysis, bronchoalveolar lavage (BAL), and high resolution computed tomography (HRCT) were evaluated and analyzed by Chi-square test or t-test. The clinical criteria for UIP proposed by ATS were applied to all patients with idiopathic interstitial pneumonia. RESULTS: Forty-two patients with UIP and 18 with NSIP were pathologically identified. Among the 18 patients with NSIP (M : F = 1 : 17), the mean age was 55.2± 8.4 (44~73)yr. Among the 42 patients with UIP (M : F = 33 : 9), the mean age was 59.5±7.1 (45~74) yr (p=0.0460. Fever was more frequent in NSIP (39%) (p=0.034), but clubbing was frequently observed in UIP (33%) (p=0.023). BAL lymphocytosis was more frequent (23%) (p=0.0001) and CD4/CD8 ratio was lower in NSIP (p=0.045). On HRCT, UIP frequently showed honeycomb appearance (36 of 42 patients) through not in NSIP (p=0.0001). Six of 42 UIP patients (14.3%) met the ATS clinical criteria for IPF, and 3 of 16 NSIP patients (18.8%) met the diagnostic criteria. CONCLUSION: Being a relatively young female and having short duration of illness, fever, BAL lymphocytosis, low CD4/CD8 ratio with the absence of clubbing and honeycomb appearance in HRCT increase the likelihood of the illness being NSIP. The usefulness of ATS clinical diagnostic criteria for UIP may be low in Korea.
Adrenal Cortex Hormones
;
Biopsy
;
Blood Gas Analysis
;
Bronchoalveolar Lavage
;
Diagnosis
;
Diagnosis, Differential*
;
Female
;
Fever
;
Humans
;
Idiopathic Interstitial Pneumonias
;
Idiopathic Pulmonary Fibrosis*
;
Korea
;
Lung
;
Lung Diseases, Interstitial*
;
Lymphocytosis
;
Prognosis
;
Pulmonary Fibrosis
;
Respiratory Function Tests
6.Partial liquid ventilation with perfluorocarbon improves gas exchange and decreases inflammatory response in oleic acid-induced lung injury in beagles.
Gee Young SUH ; Man Pyo CHUNG ; Sang Joon PARK ; Jeong Woong PARK ; Ho Cheol KIM ; Hojoong KIM ; Jeongho HAN ; Chong H RHEE ; O Jung KWON
Journal of Korean Medical Science 1999;14(6):613-622
The aim of this study was to determine the effect of partial liquid ventilation (PLV) using a perfluorocarbon (PFC) on gas exchange and lung inflammatory response in a canine acute lung injury model. After inducing severe lung injury by oleic acid infusion, beagle dogs were randomized to receive either gas ventilation only (control group, n = 6) or PLV (PLV group, n = 7) by sequential instillation of 10 mL/kg of perfluorodecalin (PFC) at 30 min intervals till functional residual capacity was attained. Measurements were made every 30 min till 210 min. Then the lungs were removed and bronchoalveolar lavage (BAL) (35 mL/kg) was performed on the right lung and the left lung was submitted for histologic analysis. There was significant improvement in PaO2 and PaCO2 in the PLV group compared to the control group (p < 0.05) which was associated with a significant decrease in shunt (p < 0.05). There was no significant difference in parameters of lung mechanics and hemodynamics. There was a significant decrease in cell count and neutrophil percentage in BAL fluid and significantly less inflammation and exudate scores in histology in the PLV group (p < 0.05). We conclude that PLV with perfluorodecalin improves gas exchange and decreases inflammatory response in the acutely-injured lung.
Animal
;
Blood Cell Count
;
Bronchoalveolar Lavage Fluid
;
Carbon Dioxide/analysis
;
Disease Models, Animal
;
Dogs
;
Female
;
Fluorocarbons/pharmacology*
;
Hemodynamics
;
Histocytochemistry
;
Inflammation/prevention & control
;
Lung Diseases/physiopathology*
;
Lung Diseases/chemically induced
;
Male
;
Oleic Acid
;
Oxygen/analysis
;
Pulmonary Gas Exchange/drug effects*
;
Pulmonary Ventilation/physiology*
;
Respiratory Function Tests
;
Ventilators, Mechanical
7.Pharmacokinetic Study of Isoniazid and Rifampicin in Healthy Korean Volunteers.
Man Pyo CHUNG ; Ho Cheol KIM ; Gee Young SUH ; Jeong Woong PARK ; Ho Joong KIM ; O Jung KWON ; Chong H RHEE ; Yong Choi HAN ; Hyo Jung PARK ; Myoung Min KIM ; Kyung Eob CHOI
Tuberculosis and Respiratory Diseases 1997;44(3):479-492
BACKGROUND: Isoniazid(INH) and rifampicin(RFP) are potent antituberculous drugs which have made tuberculous disease become decreasing. In Korea, prescribed doses of INH and RFP have been different from those recommended by American Thoracic Society. In fact they were determined by clinical experience rather than by scientific basis. Even there has been. few reports about pharmacokintic parameters of INH and RFP in healthy Koreans. METHOD: Oral pharmacokinetics of INH were studied in 22 healthy native Koreans after administration of 300mg and 400mg of INH to each same person successively at least 2 weeks apart. After an overnight fast, subjects received medication and blood samples were drawn at scheduled times over a 24-hour period. Urine college lion was also done for 24 hours. Pharmacokinetics of RFP were studied in 20 subjects in a same fashion with 450mg and 600mg of RFP. Plasma and urinary concentrations of INH and RFP were determined by high-performance liquid chromatography(HPLC). RESULTS: Time to reach peak serum concentration (Tmax) of INH was 1.05α0.34 hrs at 300mg dose and 0.98α0.59 hrs at 400mg dose. Half-life was 2.49α0.88 hrs and 2.80α0.75 hrs, respectively. They were not different significantly(p>0.05) Peak serum concentration(Cmax) after administration of 400mg of INH was 7.14α 1.95mcg/mL which was significantly higher than Cmax (4.37α1.28mcg/mL) by 300mg of INH(p<0.01). Total clearance(CLtot) of INH at 300mg dose was 26.76α11.80mL/hr. At 400mg dose it was 21.09α8.31mL/hr which was significantly lower(p<0.01) than by 300mg dose. While renal clearance(CLr) was not different among two groups nonrenal clearance(CLnr) at 400mg dose (18.18α8.36mL/hr) was significantly lower than CLnr (23.71α11.52mL/hr) by 300mg dose(p<0.01). Tmax of RFP was 1.11α0.41 tut at 450mg dose and 1.15 α0.43 hrs at 600mg dose. Half-life was 4.20α0.73 hrs and 4.95α2.25 hrs, respectively. They were not different significantly(p>0.05). Cmax after administration of 600mg of RFP was 13.61 α3.43mcg/mL which was significantly higher than Cmax(10.12α2.25mcg/mL) by 450mg of RFP(p<0.01). CLtot of RFP at 450mg dose was 7.60α1.34mL/hr. At 600mg dose it was 7.05α 1.20mL/hr which was significantly lower(p<0.05) than by 450mg dose. While CLr was not different among two groups, CLnr at 600mg dose(5.36α1.20mL/hr) was significantly lower than CLnr(6.19α 1.56mL/hr) by 450mg dose(p<0.01). CONCLUSION: Considering Cmax and CLnr, 300mg, of INH and 450mg RFP might be sufficient doses for the treatment of tuberculosis in Koreans. But it remains to be clarified in the patients with tuberculosis.
Half-Life
;
Humans
;
Isoniazid*
;
Korea
;
Lions
;
Pharmacokinetics
;
Plasma
;
Rifampin*
;
Tuberculosis
;
Volunteers*
8.A Case of Rifampicin Induced Pseudomembranous Colitis.
Jong Wook YUN ; Jung Hye HWANG ; Hyoung Suk HAM ; Han Chul LEE ; Gil Hwan ROH ; Soo Jung KANG ; Gee Young SUH ; Ho Joong KIM ; Man Pyo CHUNG ; O Jung KWON ; Chong H RHEE ; Hee Chung SON
Tuberculosis and Respiratory Diseases 2000;49(6):774-779
Pseudomembranous colitis, although uncommon, is an important complication of antibiotics that is related to a variety of deleterious effects on the gastrointestinal tract. Rifampicin is one of the 1st line agents in the treatment of tuberculosis and a large number of patients are exposed to its potential adverse effects. We report upon a patient that had diarrhea due to pseudomembranous colitis after receiving antitubeculous medication, and which was probably caused by rifampicin. A 77-year-old man was admitted with diarrhea of three weeks duration. One month previously, he suffered from left pleuritic chest pain and left pleural effusion was noticed at chest X-ray. One week prior to the onset of diarrhea, he was started on empirically isoniazid, rifampicin, ethambutol and pyrazynamide as antituberculous medication. On admission, he complained of diarrhea, left pleuritic chest pain, dyspnea and sputum. On physical examination, breathing sound was decreased in the left lower lung field and bowel sound increased. Pleural biopsy revealed chronic granulomatous infalmmation, which was compatible with tuberculosis. Sigmoidoscopy showed whitish to yellowish pseudomembrane with intervening normal mucosa, and his stool was positive for C.difficle toxin. He was diagnosed as pseudomembranous colitis and treated with oral metronidazole and vancomycin. The diarrhea did not recur after reinstitution of the anti-tuberculous medication without rifampicin. In patients with severe diarrhea receining anti-tuberculous medication, rifampicin induced pseudomembranous colitis should be excluded.
Aged
;
Anti-Bacterial Agents
;
Biopsy
;
Chest Pain
;
Clostridium difficile
;
Diarrhea
;
Dyspnea
;
Enterocolitis, Pseudomembranous*
;
Ethambutol
;
Gastrointestinal Tract
;
Humans
;
Isoniazid
;
Lung
;
Metronidazole
;
Mucous Membrane
;
Physical Examination
;
Pleural Effusion
;
Respiratory Sounds
;
Rifampin*
;
Sigmoidoscopy
;
Sputum
;
Thorax
;
Tuberculosis
;
Vancomycin
9.Clinical Value of Endobronchial Ultrasound Findings for Predicting Nodal Metastasis in Patients with Suspected Lymphadenopathy: A Prospective Study.
Byung Woo JHUN ; Sang Won UM ; Gee Young SUH ; Man Pyo CHUNG ; Hojoong KIM ; O Jung KWON ; Joungho HAN ; Kyung Jong LEE
Journal of Korean Medical Science 2014;29(12):1632-1638
We evaluated whether sonographic findings can provide additional diagnostic yield in endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), and can more accurately predict nodal metastasis than chest computed tomography (CT) or positron emission tomography (PET)/CT scans. EBUS-TBNA was performed in 146 prospectively recruited patients with suspected thoracic lymph node involvement on chest CT and PET/CT from June 2012 to January 2013. Diagnostic yields of EBUS finding categories as a prediction model for metastasis were evaluated and compared with findings of chest CT, PET/CT, and EBUS-TBNA. In total, 172 lymph nodes were included in the analysis: of them, 120 were malignant and 52 were benign. The following four EBUS findings were predictive of metastasis: nodal size > or =10 mm, round shape, heterogeneous echogenicity, and absence of central hilar structure. A single EBUS finding did not have sufficient diagnostic yield; however, when the lymph node had any one of the predictive factors on EBUS, the diagnostic yields for metastasis were higher than for chest CT and PET/CT, with a sensitivity of 99.1% and negative predictive value of 83.3%. When any one of predictive factors is observed on EBUS, subsequent TBNA should be considered, which may provide a higher diagnostic yield than chest CT or PET/CT.
Aged
;
Bronchi
;
Endoscopic Ultrasound-Guided Fine Needle Aspiration/*methods
;
Endosonography/*methods
;
Female
;
Humans
;
Lymph Nodes/*pathology/ultrasonography
;
Lymphatic Diseases/*pathology/ultrasonography
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Prospective Studies
;
Reproducibility of Results
;
Sensitivity and Specificity
;
Thoracic Neoplasms/*pathology/*secondary/ultrasonography
10.Bronchoscopic Findings of Pulmonary Paragonimiasis.
Kyeongman JEON ; Jae Uk SONG ; Sang Won UM ; Won Jung KOH ; Gee Young SUH ; Man Pyo CHUNG ; O Jung KWON ; Joungho HAN ; Hojoong KIM
Tuberculosis and Respiratory Diseases 2009;67(6):512-516
BACKGROUND: Pulmonary paragonimiasis is a subacute to chronic inflammatory disease of the lung caused by lung flukes that result in prolonged inflammation and mechanical injury to the bronchi. However, there are few reports on the bronchoscopic findings of pulmonary paragonimiasis. This report describes the bronchoscopic findings of pulmonary paragonimiasis. METHODS: The bronchosocpic findings of 30 patients (20 males, median age 50 years) with pulmonary paragonimiasis between May 1995 and December 2007 were reviewed retrospectively. RESULTS: The diagnoses were based on a positive serologic test results for Paragonimus-specific antibodies in 13 patients (43%), or the detection of Paragonimus eggs in the sputum, bronchial washing fluid, or lung biopsy specimens in 17 patients (57%). The bronchoscopic examinations revealed endobronchial lesions in 17 patients (57%), which were located within the segmental bronchi in 10 patients (59%), lobar bronchi in 6 patients (35%) and main bronchi in 1 patient (6%). The bronchoscopic characteristics of endobronchial lesions were edematous swelling of the mucosa (16/17, 94%) and mucosal nodularity (4/17, 24%), accompanied by bronchial stenosis in 16 patients (94%). Paragonimus eggs were detected in the bronchial washing fluid of 9 out of the 17 patients with endobronchial lesions. The bronchial mucosal biopsy specimens showed evidence of chronic inflammation with eosinophilic infiltration in 6 out of 11 patients (55%). However, no adult fluke or ova were found in the bronchial tissue. CONCLUSION: Bronchial stenosis with mucosal changes including edematous swelling and mucosal nodularity is the most common bronchoscopic finding of pulmonary paragonimiasis.
Adult
;
Antibodies
;
Biopsy
;
Bronchi
;
Bronchitis
;
Bronchoscopy
;
Constriction, Pathologic
;
Eggs
;
Eosinophils
;
Humans
;
Inflammation
;
Lung
;
Male
;
Mucous Membrane
;
Ovum
;
Paragonimiasis
;
Paragonimus
;
Retrospective Studies
;
Serologic Tests
;
Sputum
;
Trematoda